世界のジェネリック注射剤市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV06748)
◆英語タイトル:Global Generic Injectables Market Insights and Forecast to 2026
◆商品コード:QYR20NV06748
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはジェネリック注射剤の世界市場について調査・分析した資料です。種類別(大分子注射剤(バイオシミラー)、小分子注射剤)の市場規模、用途別(腫瘍学、感染症、心臓病学、糖尿病、免疫学)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ジェネリック注射剤の競争状況、市場シェア
・世界のジェネリック注射剤市場:種類別市場規模 2015年-2020年(大分子注射剤(バイオシミラー)、小分子注射剤)
・世界のジェネリック注射剤市場:種類別市場規模予測 2021年-2026年(大分子注射剤(バイオシミラー)、小分子注射剤)
・世界のジェネリック注射剤市場:用途別市場規模 2015年-2020年(腫瘍学、感染症、心臓病学、糖尿病、免疫学)
・世界のジェネリック注射剤市場:用途別市場規模予測 2021年-2026年(腫瘍学、感染症、心臓病学、糖尿病、免疫学)
・北米のジェネリック注射剤市場分析:米国、カナダ
・ヨーロッパのジェネリック注射剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのジェネリック注射剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のジェネリック注射剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのジェネリック注射剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Sandoz International、Baxter、Fresenius、Mylan、Teva Pharmaceutical、Hikma Pharmaceuticals、Lupin Pharmaceuticals、Sanofi、Biocon
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc.

Market Analysis and Insights: Global Generic Injectables Market
The global Generic Injectables market size is projected to reach US$ 26870 million by 2026, from US$ 25420 million in 2020, at a CAGR of 5.3%% during 2021-2026.

Global Generic Injectables Scope and Market Size
Generic Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Generic Injectables market is segmented into
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables

Segment by Application, the Generic Injectables market is segmented into
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology

Regional and Country-level Analysis
The Generic Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Generic Injectables market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Generic Injectables Market Share Analysis
Generic Injectables market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Generic Injectables business, the date to enter into the Generic Injectables market, Generic Injectables product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Sandoz International
Baxter
Fresenius
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
Lupin Pharmaceuticals
Sanofi
Biocon

【レポートの目次】

1 Study Coverage
1.1 Generic Injectables Product Introduction
1.2 Market Segments
1.3 Key Generic Injectables Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Generic Injectables Market Size Growth Rate by Type
1.4.2 Large Molecule Injectables (Biosimilars)
1.4.3 Small Molecule Injectables
1.5 Market by Application
1.5.1 Global Generic Injectables Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Infectious Diseases
1.5.4 Cardiology
1.5.5 Diabetes
1.5.6 Immunology
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Generic Injectables Market Size, Estimates and Forecasts
2.1.1 Global Generic Injectables Revenue 2015-2026
2.1.2 Global Generic Injectables Sales 2015-2026
2.2 Global Generic Injectables, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Generic Injectables Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Generic Injectables Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Generic Injectables Competitor Landscape by Players
3.1 Generic Injectables Sales by Manufacturers
3.1.1 Generic Injectables Sales by Manufacturers (2015-2020)
3.1.2 Generic Injectables Sales Market Share by Manufacturers (2015-2020)
3.2 Generic Injectables Revenue by Manufacturers
3.2.1 Generic Injectables Revenue by Manufacturers (2015-2020)
3.2.2 Generic Injectables Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Generic Injectables Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2019
3.2.5 Global Generic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Generic Injectables Price by Manufacturers
3.4 Generic Injectables Manufacturing Base Distribution, Product Types
3.4.1 Generic Injectables Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Generic Injectables Product Type
3.4.3 Date of International Manufacturers Enter into Generic Injectables Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Generic Injectables Market Size by Type (2015-2020)
4.1.1 Global Generic Injectables Sales by Type (2015-2020)
4.1.2 Global Generic Injectables Revenue by Type (2015-2020)
4.1.3 Generic Injectables Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Generic Injectables Market Size Forecast by Type (2021-2026)
4.2.1 Global Generic Injectables Sales Forecast by Type (2021-2026)
4.2.2 Global Generic Injectables Revenue Forecast by Type (2021-2026)
4.2.3 Generic Injectables Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Generic Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Generic Injectables Market Size by Application (2015-2020)
5.1.1 Global Generic Injectables Sales by Application (2015-2020)
5.1.2 Global Generic Injectables Revenue by Application (2015-2020)
5.1.3 Generic Injectables Price by Application (2015-2020)
5.2 Generic Injectables Market Size Forecast by Application (2021-2026)
5.2.1 Global Generic Injectables Sales Forecast by Application (2021-2026)
5.2.2 Global Generic Injectables Revenue Forecast by Application (2021-2026)
5.2.3 Global Generic Injectables Price Forecast by Application (2021-2026)

6 North America
6.1 North America Generic Injectables by Country
6.1.1 North America Generic Injectables Sales by Country
6.1.2 North America Generic Injectables Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Generic Injectables Market Facts & Figures by Type
6.3 North America Generic Injectables Market Facts & Figures by Application

7 Europe
7.1 Europe Generic Injectables by Country
7.1.1 Europe Generic Injectables Sales by Country
7.1.2 Europe Generic Injectables Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Generic Injectables Market Facts & Figures by Type
7.3 Europe Generic Injectables Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Generic Injectables by Region
8.1.1 Asia Pacific Generic Injectables Sales by Region
8.1.2 Asia Pacific Generic Injectables Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Generic Injectables Market Facts & Figures by Type
8.3 Asia Pacific Generic Injectables Market Facts & Figures by Application

9 Latin America
9.1 Latin America Generic Injectables by Country
9.1.1 Latin America Generic Injectables Sales by Country
9.1.2 Latin America Generic Injectables Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Generic Injectables Market Facts & Figures by Type
9.3 Central & South America Generic Injectables Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Generic Injectables by Country
10.1.1 Middle East and Africa Generic Injectables Sales by Country
10.1.2 Middle East and Africa Generic Injectables Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Generic Injectables Market Facts & Figures by Type
10.3 Middle East and Africa Generic Injectables Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Generic Injectables Products Offered
11.1.5 Pfizer Related Developments
11.2 Sandoz International
11.2.1 Sandoz International Corporation Information
11.2.2 Sandoz International Description and Business Overview
11.2.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sandoz International Generic Injectables Products Offered
11.2.5 Sandoz International Related Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Description and Business Overview
11.3.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Baxter Generic Injectables Products Offered
11.3.5 Baxter Related Developments
11.4 Fresenius
11.4.1 Fresenius Corporation Information
11.4.2 Fresenius Description and Business Overview
11.4.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Fresenius Generic Injectables Products Offered
11.4.5 Fresenius Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Generic Injectables Products Offered
11.5.5 Mylan Related Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description and Business Overview
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Generic Injectables Products Offered
11.6.5 Teva Pharmaceutical Related Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Corporation Information
11.7.2 Hikma Pharmaceuticals Description and Business Overview
11.7.3 Hikma Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hikma Pharmaceuticals Generic Injectables Products Offered
11.7.5 Hikma Pharmaceuticals Related Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Corporation Information
11.8.2 Lupin Pharmaceuticals Description and Business Overview
11.8.3 Lupin Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lupin Pharmaceuticals Generic Injectables Products Offered
11.8.5 Lupin Pharmaceuticals Related Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Description and Business Overview
11.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Generic Injectables Products Offered
11.9.5 Sanofi Related Developments
11.10 Biocon
11.10.1 Biocon Corporation Information
11.10.2 Biocon Description and Business Overview
11.10.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Biocon Generic Injectables Products Offered
11.10.5 Biocon Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Generic Injectables Products Offered
11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Generic Injectables Market Estimates and Projections by Region
12.1.1 Global Generic Injectables Sales Forecast by Regions 2021-2026
12.1.2 Global Generic Injectables Revenue Forecast by Regions 2021-2026
12.2 North America Generic Injectables Market Size Forecast (2021-2026)
12.2.1 North America: Generic Injectables Sales Forecast (2021-2026)
12.2.2 North America: Generic Injectables Revenue Forecast (2021-2026)
12.2.3 North America: Generic Injectables Market Size Forecast by Country (2021-2026)
12.3 Europe Generic Injectables Market Size Forecast (2021-2026)
12.3.1 Europe: Generic Injectables Sales Forecast (2021-2026)
12.3.2 Europe: Generic Injectables Revenue Forecast (2021-2026)
12.3.3 Europe: Generic Injectables Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Generic Injectables Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Generic Injectables Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Generic Injectables Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Generic Injectables Market Size Forecast by Region (2021-2026)
12.5 Latin America Generic Injectables Market Size Forecast (2021-2026)
12.5.1 Latin America: Generic Injectables Sales Forecast (2021-2026)
12.5.2 Latin America: Generic Injectables Revenue Forecast (2021-2026)
12.5.3 Latin America: Generic Injectables Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Generic Injectables Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Generic Injectables Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Generic Injectables Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Generic Injectables Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Generic Injectables Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Generic Injectables Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Pfizer、Sandoz International、Baxter、Fresenius、Mylan、Teva Pharmaceutical、Hikma Pharmaceuticals、Lupin Pharmaceuticals、Sanofi、Biocon

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のジェネリック注射剤市場2026:インサイト・予測(Global Generic Injectables Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。